Sextant Therapeutics Company
Sextant is developing personalized cancer therapies that trigger the tumor to recruit the patient's own cancer-killing immune response.
Technology:
Data-driven Technologies
Industry:
PharmTech
Headquarters:
Cambridge, Massachusetts, United States
Founded Date:
1/1/2011
Employees Number:
1-10
Last Funding Type:
Grant
Register and Claim Ownership